Form 8-K - Current report:
SEC Accession No. 0000950123-05-013626
Filing Date
2005-11-14
Accepted
2005-11-14 16:34:02
Documents
2
Period of Report
2005-11-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y14780ae8vk.htm 8-K 13983
2 EX-99.1: SCRIPT OF WEBCAST CONFERENCE CALL y14780aexv99w1.htm EX-99.1 8475
  Complete submission text file 0000950123-05-013626.txt   24096
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 051202062
SIC: 2835 In Vitro & In Vivo Diagnostic Substances